首頁 > 市場調查報告書 > 醫療設備

醫學影像診斷核子醫學

全球輻射劑量管理市場（至 2031 年）：按功能（劑量監測、基準測試、報告、輻射管理）、技術（人工智慧）、部署模式、模式（CT、PET、SPECT）、應用（癌症）和最終用戶（醫院）分類

市場調查報告書

商品編碼

2129357

全球輻射劑量管理市場（至 2031 年）：按功能（劑量監測、基準測試、報告、輻射管理）、技術（人工智慧）、部署模式、模式（CT、PET、SPECT）、應用（癌症）和最終用戶（醫院）分類

Radiation Dose Management Market by Function (Dose Monitoring, Benchmarking, Reporting, Radiation Management), Technology (AI ), Deployment, Modality (CT, PET, SPECT), Application (Onco), End User (Hospital) - Global Forecast to 2031

出版日期: 2026年09月03日 | 出版商:

MarketsandMarkets | 英文 489 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

預計到 2031 年，輻射劑量管理市場規模將達到 9.6 億美元，高於 2026 年的 5.1 億美元，2026 年至 2031 年的複合年成長率為 13.3%。

受醫療影像診斷的廣泛應用、患者對輻射安全的日益關注、更加嚴格的法規強調輻射劑量監測和最佳化以及自動化劑量管理系統的日益普及等因素的推動，市場正在穩步成長。

調查範圍
調查期	2026-2031
基準年	2025
預測期	2026-2031
單元	金額（美元）
部分	交付類別、功能、技術、部署方法、收入模式、模式、應用程式、最終用戶、區域
目標區域	北美、歐洲、亞太地區、拉丁美洲、中東和非洲

診斷影像程序的數量和複雜性不斷增加，加速了醫院、醫療保健系統、診斷和影像中心以及其他影像機構對輻射劑量管理 (RDM) 系統的應用。這些系統使醫療機構能夠收集、監測、儲存、分析和共用患者輻射劑量數據，識別劑量差異，比較不同機構和程序之間的輻射暴露情況，支持診斷參考水平 (DRL)，並最佳化診斷成像實踐。

“按服務類別分類，解決方案將在 2025 年佔據最大的市場佔有率。”

這主要得益於醫療影像環境中輻射劑量數據的自動化採集、監測、分析、報告、基準測試和最佳化等軟體平台的日益普及。輻射劑量管理 (RDM) 解決方案使醫療機構能夠從多種影像模式中採集和分析輻射計量信息，識別劑量變異性和異常值，並將其與診斷參考水平 (DRL) 進行比較，從而幫助最佳化影像方案。從獨立的劑量追蹤工具朝向整合且可互通的劑量管理平台的轉變，也推動了解決方案領域的成長。這些平台將影像設備與 PACS、RIS、醫院資訊系統和其他醫療IT基礎設施連接起來。預計在整個預測期內，自動化警報、劑量分析、患者劑量追蹤和高級最佳化功能的持續應用將支撐對 RDM 解決方案的需求。

“按部署模式來看，預計在預測期內，基於雲端的部署將呈現高速成長。”

預計在預測期內，基於雲端/網路的劑量管理系統細分市場將保持較高的複合年成長率，這主要得益於醫院、診斷和影像中心以及多站點醫療網路對集中式、遠端存取劑量管理系統日益成長的需求。基於雲端和網路的劑量資料管理（RDM）平台使醫療機構能夠跨機構存取劑量信息，支援集中式監測和基準測試，並減少對大規模現場基礎設施的需求。此外，將劑量數據與PACS、RIS和其他醫療資訊系統整合的需求不斷成長，也推動了這些部署模式的普及。

“到2025年，北美將佔據最大的市場佔有率。”

完善的醫療基礎設施、先進醫學影像技術的高普及率、龐大的影像檢查量以及人們對輻射安全和劑量最佳化的日益關注，都為這一趨勢提供了支撐。美國和加拿大擁有成熟的醫療體系，CT、透視、介入影像、放射線攝影、乳房乳房X光攝影和核子醫學等技術已廣泛應用，對監測和管理輻射暴露的技術產生了強勁的需求。該地區的醫療機構正擴大採用輻射劑量管理（RDM）解決方案，以支援自動劑量監測、識別劑量變異性、輻射暴露基準測試以及最佳化影像方案。成熟的RDM供應商和完善的醫療IT生態系統也進一步推動了醫院、醫療系統和診斷影像機構對劑量管理技術的應用。隨著先進影像技術的不斷擴展以及對患者安全和高效劑量管理的日益重視，預計北美將在整個預測期內保持主導地位。

本報告檢視了全球輻射劑量管理市場，提供了市場概述、影響市場成長的各種因素分析、技術和專利趨勢、法律制度、案例研究、市場規模趨勢和預測、按各個細分市場和地區/主要國家進行的詳細分析、競爭格局以及主要公司的概況。

波特五力分析
總體經濟指標
- GDP趨勢與預測
- 全球醫療保健IT產業趨勢
價值鏈分析
生態系分析
價格分析
重要會議和活動
影響客戶業務的趨勢和顛覆性因素
投資和資金籌措場景
案例研究分析
美國關稅影響概述
價格影響分析
對國家和地區的影響
對最終用戶的影響

第6章：透過引進技術、專利、數位技術和人工智慧實現策略顛覆

主要新興技術
- 基於人工智慧的輻射劑量預測、監測和最佳化。
- 患者特定/個人化劑量測定技術
- 用於最佳化輻射劑量的先進影像診斷技術
互補技術
- DICOM、結構化輻射劑量報告 (RDSR)、互通性操作技術
- 基於雲端的、廠商中立的、企業級劑量管理架構
- 劑量登記、基準測試、人群劑量分析
鄰近技術
- 電腦化劑量測量和患者特定劑量建模
技術/產品藍圖
專利分析
未來應用
- 人工智慧輔助的個人化輻射劑量管理
- 即時劑量最佳化和智慧影像診斷工作流程自動化
- 長期輻射暴露管理與預測劑量分析
人工智慧/生成式人工智慧對輻射劑量管理市場的影響

第7章監理情勢

當地法規和合規性

第8章：顧客趨勢與購買行為

決策流程
相關人員及購買評估標準
採購過程中的關鍵相關人員
實施障礙和內部挑戰
來自不同最終用戶的未滿足需求
市場盈利

第9章輻射劑量管理市場：依產品類別分類

解決方案
- 獨立解決方案
- 整合解決方案
服務
- 支援和維護服務
- 實施和整合服務
- 諮詢服務
- 教育及培訓服務

第10章輻射劑量管理市場：依功能分類

劑量追蹤和監測
劑量分析和基準測試
劑量報告和監管合規性
方案和劑量最佳化
患者輻射暴露管理
其他

第11章輻射劑量控制市場：依技術分類

人工智慧技術
- 機器學習
- 深度學習
- 電腦視覺
- 自然語言處理（NLP）
非人工智慧/傳統技術

第12章輻射劑量管理市場：依實施型分類

本地部署
基於雲端/Web

第13章：輻射劑量管理市場：依收入模式分類

一次性購買/年度購買模式
計量收費模式

第14章輻射劑量管理市場：依治療方式分類

電腦斷層掃描（CT）
透視和介入性影像
X光
乳房X光檢查
核子醫學
- PET
- SPECT
- 混合

第15章輻射劑量控制市場：依應用領域分類

癌症
心
整形外科
牙科
其他

第16章輻射劑量管理市場：依最終用戶分類

醫院和醫療保健系統
- 診斷和影像中心
- 門診部
- 學術和研究機構
- 其他

第17章輻射劑量管理市場：依地區分類

北美洲
- 宏觀經濟展望
- 美國
- 加拿大
歐洲
- 宏觀經濟展望
- 德國
- 法國
- 英國
- 義大利
- 西班牙
- 其他
亞太地區
- 宏觀經濟展望
- 中國
- 日本
- 印度
- 澳洲
- 韓國
- 其他
拉丁美洲
- 宏觀經濟展望
- 巴西
- 墨西哥
- 其他
中東和非洲
- 宏觀經濟展望
- 海灣合作理事會國家
- 南非
- 其他

第18章競爭格局

概述
主要參與企業的策略/優勢
收入分析
市佔率分析
品牌對比
企業估值和財務指標
企業估值矩陣：主要公司
公司估值矩陣：新創企業/中小企業
競爭格局

第19章：公司簡介

大公司
- BAYER AG
- SIEMENS HEALTHINEERS AG
- KONINKLIJKE PHILIPS NV
- GE HEALTHCARE
- FUJIFILM HOLDINGS CORPORATION
- SECTRA AB
- CANON INC.
- AGFA-GEVAERT NV
- PACSHEALTH, LLC
- QAELUM
- MEDSQUARE
- NOVARAD
- INFINITT HEALTHCARE CO., LTD.
- CARESTREAM HEALTH
- SHIMADZU CORPORATION
- NANJING PERLOVE MEDICAL EQUIPMENT CO., LTD.
- NEUSOFT MEDICAL SYSTEMS CO., LTD.
- KONICA MINOLTA, INC
- IBA
- LUNIT INC.
其他公司
- QIT SYSTEME GMBH
- IMALOGIX
- IDOSE
- MYXRAYDOSE LTD.
- VIRTUAL PHANTOMS INC.

第20章：調查方法

第21章附錄

簡介目錄圖表

Product Code: HIT 3247

The radiation dose management market is projected to reach USD 0.96 billion by 2031 from USD 0.51 billion in 2026, at a CAGR of 13.3% from 2026 to 2031. The market is experiencing steady growth owing to the increasing utilization of medical imaging procedures, rising focus on patient radiation safety, regulatory emphasis on radiation dose monitoring and optimization, and growing adoption of automated dose management systems.

Scope of the Report
Years Considered for the Study	2026-2031
Base Year	2025
Forecast Period	2026-2031
Units Considered	Value (USD billion)
Segments	Offering, Function, Technology Deployment Model, Revenue Model, Modality, Application, End User, and Region
Regions covered	North America, Europe, Asia Pacific, Latin America, and Middle East & Africa

The increasing volume and complexity of imaging procedures are accelerating the use of RDM systems across hospitals, healthcare systems, diagnostic and imaging centers, and other imaging facilities. These systems enable healthcare organizations to collect, monitor, archive, analyze, and share patient radiation dose data; identify dose variations; compare radiation exposure across facilities and procedures; support diagnostic reference levels (DRLs); and optimize imaging practices.

"By offering, solutions accounted for the dominant share of the radiation dose management market in 2025."

Based on offering, the radiation dose management market is segmented into solutions and services. The solutions segment accounted for the dominant share of the market in 2025, driven by the increasing adoption of software platforms that automate radiation-dose data collection, monitoring, analysis, reporting, benchmarking, and optimization across medical imaging environments. RDM solutions enable healthcare organizations to collect and analyze dose information from multiple imaging modalities, identify dose variations and outliers, compare radiation exposure against diagnostic reference levels (DRLs), and support imaging-protocol optimization. The solutions segment is also benefiting from the shift from standalone dose-tracking tools toward integrated and interoperable dose-management platforms that connect imaging modalities with PACS, RIS, hospital information systems, and other healthcare IT infrastructure. The continued adoption of automated alerts, dose analytics, patient dose tracking, and advanced optimization capabilities is expected to support demand for RDM solutions throughout the forecast period.

"By deployment model, the cloud-based deployment is expected to witness high growth during the forecast period."

Based on deployment model, the radiation dose management market is segmented into on-premises and cloud-based/web-based deployment. The cloud-based/web-based deployment segment is expected to register higher CAGR during the forecast period, supported by the increasing need for centralized and remotely accessible dose-management systems across hospitals, diagnostic and imaging centers, and multi-site healthcare networks. Cloud-based and web-based RDM platforms allow healthcare organizations to access dose information across facilities, support centralized monitoring and benchmarking, and reduce the need for extensive on-site infrastructure. The adoption of these deployment models is further supported by the growing need to integrate dose data with PACS, RIS, and other healthcare information systems.

"North America accounted for the largest share of the radiation dose management market in 2025."

The radiation dose management market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America accounted for the largest share of the market in 2025, supported by well-established healthcare infrastructure, high adoption of advanced medical imaging technologies, large imaging volumes, and increasing emphasis on radiation safety and dose optimization. The US and Canada have mature healthcare systems with widespread use of CT, fluoroscopy, and interventional imaging, radiography, mammography, and nuclear medicine, creating strong demand for technologies that monitor and manage radiation exposure. Healthcare organizations across the region are increasingly adopting RDM solutions to automate dose monitoring, identify dose variations, benchmark radiation exposure, and support imaging protocol optimization. The presence of established RDM providers and a mature healthcare IT ecosystem further supports adoption of dose management technologies across hospitals, healthcare systems, and diagnostic imaging facilities. The continued expansion of advanced imaging and growing focus on patient safety and efficient dose management are expected to sustain North America's leading position in the RDM market during the forecast period.

The breakdown of primary interview participants is as mentioned below:

By Company Type: Tier 1 - 45%, Tier 2 - 35%, and Tier 3 - 20%
By Designation: C-level Executives - 26%, Directors - 17%, and Others - 57%
By Region: North America - 40%, Europe - 20%, Asia Pacific - 30%, Latin America- 6%, and Middle East - 4%

Bayer AG (Germany) and GE HealthCare (US) are among the key players in the radiation dose management market.

The study includes an in-depth competitive analysis of these key players in the radiation dose management market, with their company profiles, recent developments, and key market strategies.

Research Coverage

The report analyzes the radiation dose management market. It aims to estimate the market size and future growth potential of various market segments based on offering, function, technology, deployment model, revenue model, modality, application, end user, and region. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to buy this report

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the radiation dose management market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights into the following pointers:

Analysis of key drivers (increasing utilization and complexity of imaging procedures, increasing regulatory emphasis on dose monitoring, optimization, and reference levels, growing concerns regarding radiation exposure and dose optimization), restraints (high implementation, integration, and maintenance costs, shortage of skilled professionals for radiation dose management and optimization), opportunities (increasing adoption of AI-enabled radiation dose optimization, growing adoption of vendor-neutral and cloud-based dose management platforms, increasing focus on age-specific radiation dose optimization), and challenges (lack of standardized and interoperable dose data across modalities and systems, variability in dose benchmarks and imaging protocols across institutions) influencing the growth of the radiation dose management market
Product Development/Innovation: Detailed insights into upcoming technologies, research & development activities, and new product & service launches in the radiation dose management market
Market Development: Comprehensive information about lucrative markets (the report analyzes the radiation dose management market across varied regions)
Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the radiation dose management market
Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players such as Bayer AG (Germany), GE HealthCare (US), Koninklijke Philips N.V. (Netherlands), Siemens Healthineers AG (Germany), Sectra AB (Sweden), and FUJIFILM Holdings Corporation (Japan)

1 INTRODUCTION

1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
- 1.3.1 MARKETS COVERED
- 1.3.2 INCLUSIONS AND EXCLUSIONS
- 1.3.3 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES

2 EXECUTIVE SUMMARY

2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS
2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS AND STRATEGIC DEVELOPMENTS
2.3 DISRUPTIVE TRENDS SHAPING MARKET
2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS
2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST

3 PREMIUM INSIGHTS

3.1 RADIATION DOSE MANAGEMENT MARKET OVERVIEW
3.2 NORTH AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY OFFERING AND COUNTRY
3.3 RADIATION DOSE MANAGEMENT MARKET: REGIONAL GROWTH OPPORTUNITIES

4 MARKET OVERVIEW

4.1 INTRODUCTION
4.2 MARKET DYNAMICS
- 4.2.1 DRIVERS
  - 4.2.1.1 Increasing utilization and complexity of imaging procedures
  - 4.2.1.2 Increasing regulatory emphasis on dose monitoring, optimization, and reference levels
  - 4.2.1.3 Growing concerns regarding radiation exposure and dose optimization
- 4.2.2 RESTRAINTS
  - 4.2.2.1 High implementation and integration costs
  - 4.2.2.2 Shortage of skilled professionals for radiation dose management and optimization
- 4.2.3 OPPORTUNITIES
  - 4.2.3.1 Increasing adoption of AI-enabled radiation dose optimization
  - 4.2.3.2 Growing adoption of vendor-neutral and cloud-based dose management platforms
  - 4.2.3.3 Increasing focus on age-specific radiation dose optimization
- 4.2.4 CHALLENGES
  - 4.2.4.1 Lack of standardized and interoperable dose data across modalities and systems
  - 4.2.4.2 Variability in dose benchmarks and imaging protocols across institutions
4.3 UNMET NEEDS AND WHITE SPACES
4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS

5 INDUSTRY TRENDS

5.1 PORTER'S FIVE FORCES ANALYSIS
- 5.1.1 THREAT OF NEW ENTRANTS
- 5.1.2 THREAT OF SUBSTITUTES
- 5.1.3 BARGAINING POWER OF SUPPLIERS
- 5.1.4 BARGAINING POWER OF BUYERS
- 5.1.5 INTENSITY OF COMPETITIVE RIVALRY
5.2 MACROECONOMIC INDICATORS
- 5.2.1 INTRODUCTION
- 5.2.2 GDP TRENDS AND FORECAST
- 5.2.3 TRENDS IN GLOBAL HEALTHCARE IT INDUSTRY
5.3 VALUE CHAIN ANALYSIS
- 5.3.1 RESEARCH & PRODUCT DEVELOPMENT
- 5.3.2 DATA & KNOWLEDGE ASSETS
- 5.3.3 SOFTWARE & PLATFORM INFRASTRUCTURE
- 5.3.4 CLOUD SERVICE PROVIDERS
- 5.3.5 MARKETING & SALES
- 5.3.6 POST-SALES SERVICES
5.4 ECOSYSTEM ANALYSIS
5.5 PRICING ANALYSIS
- 5.5.1 INDICATIVE PRICE FOR RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT (2025)
- 5.5.2 INDICATIVE PRICE FOR RADIATION DOSE MANAGEMENT MARKET, BY REGION (2025)
5.6 KEY CONFERENCES AND EVENTS
5.7 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
5.8 INVESTMENT AND FUNDING SCENARIO
5.9 CASE STUDY ANALYSIS
- 5.9.1 REDUCING CT DOSE THROUGH REAL-TIME DOSE MONITORING AND ALERTING
- 5.9.2 ESTABLISHING ENTERPRISE-WIDE, MULTI-MODALITY DOSE MANAGEMENT
- 5.9.3 REDUCED RADIATION DOSE IN SPECIALIST CANCER CARE
- 5.9.4 IMPROVED CARE COORDINATION
5.10 IMPACT OF US TARIFF OVERVIEW
- 5.10.1 INTRODUCTION
- 5.10.2 KEY TARIFF RATES
5.11 PRICE IMPACT ANALYSIS
5.12 IMPACT ON COUNTRY/REGION
- 5.12.1 US
- 5.12.2 EUROPE
- 5.12.3 ASIA PACIFIC
5.13 IMPACT ON END USERS
- 5.13.1 HOSPITALS AND HEALTHCARE SYSTEMS
- 5.13.2 DIAGNOSTIC AND IMAGING CENTERS
- 5.13.3 AMBULATORY SURGERY CENTERS
- 5.13.4 OTHER END USERS

6 STRATEGIC DISRUPTION THROUGH TECHNOLOGY, PATENTS, DIGITAL, AND AI ADOPTION

6.1 KEY EMERGING TECHNOLOGIES
- 6.1.1 AI-ENABLED RADIATION DOSE PREDICTION, MONITORING, AND OPTIMIZATION
- 6.1.2 PATIENT-SPECIFIC AND PERSONALIZED DOSIMETRY TECHNOLOGIES
- 6.1.3 ADVANCED IMAGING TECHNOLOGIES FOR RADIATION DOSE OPTIMIZATION
6.2 COMPLEMENTARY TECHNOLOGIES
- 6.2.1 DICOM, RADIATION DOSE STRUCTURED REPORTS (RDSR), AND INTEROPERABILITY TECHNOLOGIES
- 6.2.2 CLOUD-BASED, VENDOR-NEUTRAL, AND ENTERPRISE DOSE MANAGEMENT ARCHITECTURES
- 6.2.3 DOSE REGISTRIES, BENCHMARKING, AND POPULATION-LEVEL DOSE ANALYTICS
6.3 ADJACENT TECHNOLOGIES
- 6.3.1 COMPUTATIONAL DOSIMETRY AND PATIENT-SPECIFIC DOSE MODELING
6.4 TECHNOLOGY/PRODUCT ROADMAP
6.5 PATENT ANALYSIS
- 6.5.1 PATENT PUBLICATION TRENDS FOR RADIATION DOSE MANAGEMENT
- 6.5.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
6.6 FUTURE APPLICATIONS
- 6.6.1 AI-ASSISTED PERSONALIZED RADIATION DOSE MANAGEMENT
- 6.6.2 REAL-TIME DOSE OPTIMIZATION AND INTELLIGENT IMAGING WORKFLOW AUTOMATION
- 6.6.3 LONGITUDINAL RADIATION-EXPOSURE MANAGEMENT AND PREDICTIVE DOSE ANALYTICS
6.7 IMPACT OF AI/GEN AI ON RADIATION DOSE MANAGEMENT MARKET
- 6.7.1 INTRODUCTION
- 6.7.2 POTENTIAL OF AI/GEN AI IN RADIATION DOSE MANAGEMENT MARKET
- 6.7.3 CASE STUDIES RELATED TO AI/GEN AI IMPLEMENTATION
- 6.7.4 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS
- 6.7.5 MEDICAL IMAGING EQUIPMENT & IMAGING INFORMATICS
- 6.7.6 DOSE REGISTRIES, BENCHMARKING & QUALITY MANAGEMENT
- 6.7.7 AI-ENABLED IMAGING & CLINICAL WORKFLOW
- 6.7.8 USER READINESS AND IMPACT ASSESSMENT
  - 6.7.8.1 User readiness
    - 6.7.8.1.1 User A: Hospitals & integrated health systems
    - 6.7.8.1.2 User B: Practices outpatient diagnostic imaging centers & radiology practices
    - 6.7.8.1.3 User C: Interventional radiology & cardiology centers
  - 6.7.8.2 Impact assessment
    - 6.7.8.2.1 User A: Hospitals & integrated health systems
      - 6.7.8.2.1.1 Implementation
      - 6.7.8.2.1.2 Impact
    - 6.7.8.2.2 User B: Outpatient diagnostic imaging centers & radiology practices
      - 6.7.8.2.2.1 Implementation
      - 6.7.8.2.2.2 Impact
    - 6.7.8.2.3 User C: Interventional radiology & cardiology centers
      - 6.7.8.2.3.1 Implementation
      - 6.7.8.2.3.2 Impact

7 REGULATORY LANDSCAPE

7.1 REGIONAL REGULATIONS AND COMPLIANCE
- 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- 7.1.2 REGULATORY FRAMEWORK
  - 7.1.2.1 North America
  - 7.1.2.2 Europe
  - 7.1.2.3 Asia Pacific
  - 7.1.2.4 Latin America
  - 7.1.2.5 Middle East & Africa
- 7.1.3 INDUSTRY STANDARDS

8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR

8.1 INTRODUCTION
8.2 DECISION-MAKING PROCESS
8.3 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
8.4 KEY STAKEHOLDERS IN BUYING PROCESS
- 8.4.1 KEY STAKEHOLDERS IN BUYING PROCESS
- 8.4.2 BUYING CRITERIA
8.5 ADOPTION BARRIERS & INTERNAL CHALLENGES
8.6 UNMET NEEDS FROM VARIOUS END USERS
- 8.6.1 UNMET NEEDS
- 8.6.2 END USER EXPECTATIONS
8.7 MARKET PROFITABILITY

9 RADIATION DOSE MANAGEMENT MARKET, BY OFFERING

9.1 INTRODUCTION
9.2 SOLUTIONS
- 9.2.1 GROWING ADOPTION OF INTEGRATED AND AUTOMATED RADIATION DOSE MANAGEMENT SOLUTIONS TO DRIVE MARKET
- 9.2.2 STANDALONE SOLUTIONS
  - 9.2.2.1 Growing demand for flexible and cost-effective dose monitoring solutions to boost market
- 9.2.3 INTEGRATED SOLUTIONS
  - 9.2.3.1 Growing need for enterprise-wide, multi-vendor dose management to propel market
9.3 SERVICES
- 9.3.1 GROWING NEED FOR SPECIALIZED IMPLEMENTATION, CONSULTING, AND TRAINING EXPERTISE TO BOOST MARKET
- 9.3.2 SUPPORT & MAINTENANCE SERVICES
  - 9.3.2.1 Growing need for continuous system availability and software updates to boost market
- 9.3.3 IMPLEMENTATION & INTEGRATION SERVICES
  - 9.3.3.1 Growing hospital networks to drive demand for implementation and integration services
- 9.3.4 CONSULTING SERVICES
  - 9.3.4.1 Growing need to interpret dose trends and identify outliers to drive segment
- 9.3.5 EDUCATION & TRAINING SERVICES
  - 9.3.5.1 Increasing need for skilled personnel to support radiation dose optimization to boost segment

10 RADIATION DOSE MANAGEMENT MARKET, BY FUNCTION

10.1 INTRODUCTION
10.2 DOSE TRACKING & MONITORING
- 10.2.1 INCREASING ADOPTION OF AUTOMATED AND CONTINUOUS DOSE MONITORING
10.3 DOSE ANALYTICS & BENCHMARKING
- 10.3.1 GROWING NEED TO IDENTIFY DOSE OUTLIERS AND BENCHMARK IMAGING PERFORMANCE BOOSTS SEGMENT
10.4 DOSE REPORTING & REGULATORY COMPLIANCE
- 10.4.1 INCREASING REGULATORY EMPHASIS ON RADIATION DOSE DOCUMENTATION TO PROPEL SEGMENT
10.5 PROTOCOL & DOSE OPTIMIZATION
- 10.5.1 SEGMENT DRIVEN BY INCREASING FOCUS ON DOSE REDUCTION WHILE MAINTAINING DIAGNOSTIC IMAGE QUALITY
10.6 PATIENT RADIATION EXPOSURE MANAGEMENT
- 10.6.1 GROWING FOCUS ON PATIENT-SPECIFIC AND CUMULATIVE RADIATION EXPOSURE - KEY DRIVER
10.7 OTHER FUNCTIONS
- 10.7.1 INCREASING NEED FOR INTEROPERABILITY ACROSS HETEROGENEOUS IMAGING ENVIRONMENTS TO DRIVE SEGMENT

11 RADIATION DOSE MANAGEMENT MARKET, BY TECHNOLOGY

11.1 INTRODUCTION
11.2 AI-ENABLED TECHNOLOGY
- 11.2.1 GROWING ADOPTION OF AI DRIVES SEGMENT GROWTH
- 11.2.2 MACHINE LEARNING
  - 11.2.2.1 Growing adoption of predictive and patient-specific dose optimization to boost segment
- 11.2.3 DEEP LEARNING
  - 11.2.3.1 Increasing use of deep learning for automated imaging and dose optimization
- 11.2.4 COMPUTER VISION
  - 11.2.4.1 Increasing automation of image analysis and anatomical assessment to drive segment
- 11.2.5 NATURAL LANGUAGE PROCESSING (NLP)
  - 11.2.5.1 Increasing availability of unstructured clinical data - key driver
11.3 NON-AI/CONVENTIONAL TECHNOLOGY
- 11.3.1 ESTABLISHED CLINICAL ADOPTION AND REGULATORY RELIABILITY

12 RADIATION DOSE MANAGEMENT MARKET, BY DEPLOYMENT MODEL

12.1 INTRODUCTION
12.2 ON-PREMISE DEPLOYMENT
- 12.2.1 STRINGENT DATA-SECURITY POLICIES DRIVES SEGMENT GROWTH
12.3 CLOUD-BASED/WEB-BASED DEPLOYMENT
- 12.3.1 INCREASING NEED FOR SCALABLE, MULTI-SITE DOSE MONITORING AND REMOTE ACCESS TO IMAGING ANALYTICS BOOSTS DEMAND

13 RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL

13.1 INTRODUCTION
13.2 CAPITAL/ANNUAL PURCHASE MODEL
- 13.2.1 ESTABLISHED PROCUREMENT PRACTICES DRIVE DEMAND
13.3 PAY-PER-PROCEDURE MODEL
- 13.3.1 AFFORDABILITY DRIVES SEGMENT GROWTH

14 RADIATION DOSE MANAGEMENT MARKET, BY MODALITY

14.1 INTRODUCTION
14.2 COMPUTED TOMOGRAPHY (CT)
- 14.2.1 RAPID ADOPTION OF PHOTON-COUNTING CT AND AI-BASED RECONSTRUCTION TO DRIVE SEGMENT
14.3 FLUOROSCOPY & INTERVENTIONAL IMAGING
- 14.3.1 RISING PROCEDURAL COMPLEXITY INCREASES DEMAND FOR REAL-TIME RADIATION DOSE REDUCTION
14.4 RADIOGRAPHY
- 14.4.1 DIGITAL RADIOGRAPHY AND AI-BASED IMAGE ENHANCEMENT ENABLE LOWER EXPOSURE
14.5 MAMMOGRAPHY
- 14.5.1 EXPANSION OF 3D BREAST IMAGING DRIVES DEMAND
14.6 NUCLEAR MEDICINE
- 14.6.1 INCREASING USE OF HIGH-SENSITIVITY PET/SPECT AND AI-ENABLED RECONSTRUCTION TO DRIVE SEGMENT
- 14.6.2 PET
  - 14.6.2.1 Higher PET sensitivity and AI reconstruction to boost demand
- 14.6.3 SPECT
  - 14.6.3.1 Low-dose SPECT/CT technologies strengthen radiation optimization
- 14.6.4 HYBRID
  - 14.6.4.1 Growing reliance on PET/CT and SPECT/CT drives market

15 RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION

15.1 INTRODUCTION
15.2 ONCOLOGY
- 15.2.1 INCREASING FOCUS ON ONCOLOGY DRIVES DEMAND
15.3 CARDIOLOGY
- 15.3.1 INCREASING USE IN CARDIOLOGY BOOSTS DEMAND
15.4 ORTHOPEDIC
- 15.4.1 HIGH COMPLEXITY OF PROCEDURES DRIVES DEMAND
15.5 DENTAL
- 15.5.1 GROWING USE OF CBCT PROPELS DEMAND
15.6 OTHER APPLICATIONS
- 15.6.1 NEED TO MANAGE REPEATED EXAMINATIONS DRIVES DEMAND

16 RADIATION DOSE MANAGEMENT MARKET, BY END USER

16.1 INTRODUCTION
16.2 HOSPITALS & HEALTHCARE SYSTEMS
- 16.2.1 DIVERSE IMAGING FLEETS DRIVE CENTRALIZED RDM AND PROTOCOL OPTIMIZATION ACROSS HOSPITAL NETWORKS
16.3 DIAGNOSTIC & IMAGING CENTERS
- 16.3.1 HIGH EXAMINATION VOLUMES AND MULTI-SITE IMAGING OPERATIONS ACCELERATE DEMAND
16.4 AMBULATORY CARE SETTINGS
- 16.4.1 EXPANSION OF OUTPATIENT AND AMBULATORY IMAGING INCREASES DEMAND
16.5 ACADEMIC & RESEARCH INSTITUTES
- 16.5.1 SEGMENT DRIVEN BY AI-DRIVEN LOW-DOSE IMAGING AND NEXT-GENERATION DOSE OPTIMIZATION TECHNOLOGIES
16.6 OTHER END USERS
- 16.6.1 REGULATORY OVERSIGHT, POPULATION-LEVEL RADIATION MONITORING, AND CLINICAL-TRIAL - KEY DRIVERS

17 RADIATION DOSE MANAGEMENT MARKET, BY REGION

17.1 INTRODUCTION
17.2 NORTH AMERICA
- 17.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
- 17.2.2 US
  - 17.2.2.1 Regulatory focus on radiation safety drives market
- 17.2.3 CANADA
  - 17.2.3.1 Increasing number of diagnostic imaging procedures to boost market
17.3 EUROPE
- 17.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
- 17.3.2 GERMANY
  - 17.3.2.1 Rising diagnostic imaging demand and aging population to drive market
- 17.3.3 FRANCE
  - 17.3.3.1 Healthcare modernization to accelerate radiation dose management adoption
- 17.3.4 UK
  - 17.3.4.1 Rising imaging volumes and NHS digitalization to support market growth
- 17.3.5 ITALY
  - 17.3.5.1 Regulatory emphasis on dose optimization and monitoring to propel market
- 17.3.6 SPAIN
  - 17.3.6.1 Growing focus on patient dosimetry and radiation dose optimization to drive market
- 17.3.7 REST OF EUROPE
17.4 ASIA PACIFIC
- 17.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
- 17.4.2 CHINA
  - 17.4.2.1 Largest patient pool and increased healthcare spending to aid market growth
- 17.4.3 JAPAN
  - 17.4.3.1 Large and technologically advanced hospital infrastructure
- 17.4.4 INDIA
  - 17.4.4.1 Favorable government policies and improved healthcare infrastructure to support market growth
- 17.4.5 AUSTRALIA
  - 17.4.5.1 Advancement of national diagnostic reference levels to accelerate radiation dose optimization
- 17.4.6 SOUTH KOREA
  - 17.4.6.1 Increasing medical imaging volumes and patient radiation exposure to boost market
- 17.4.7 REST OF ASIA PACIFIC
17.5 LATIN AMERICA
- 17.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
- 17.5.2 BRAZIL
  - 17.5.2.1 Increasing regulatory focus and adoption of advanced imaging technologies to drive market
- 17.5.3 MEXICO
  - 17.5.3.1 Rising demand for diagnostic imaging and adoption of lower-dose technologies to support market growth
- 17.5.4 REST OF LATIN AMERICA
17.6 MIDDLE EAST & AFRICA
- 17.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
- 17.6.2 GCC COUNTRIES
  - 17.6.2.1 Saudi Arabia
    - 17.6.2.1.1 Growing healthcare expenditure to boost market growth
  - 17.6.2.2 UAE
    - 17.6.2.2.1 Increasing healthcare infrastructure investments to drive market growth
  - 17.6.2.3 Rest of GCC
- 17.6.3 SOUTH AFRICA
  - 17.6.3.1 Increasing focus on radiation dose optimization to propel market growth
- 17.6.4 REST OF MIDDLE EAST & AFRICA

18 COMPETITIVE LANDSCAPE

18.1 OVERVIEW
18.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2023-2026
18.3 REVENUE ANALYSIS, 2021-2025
18.4 MARKET SHARE ANALYSIS, 2021-2025
18.5 BRAND COMPARISON
18.6 COMPANY VALUATION AND FINANCIAL METRICS
18.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
- 18.7.1 STARS
- 18.7.2 EMERGING LEADERS
- 18.7.3 PERVASIVE PLAYERS
- 18.7.4 PARTICIPANTS
- 18.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
  - 18.7.5.1 Company footprint
  - 18.7.5.2 Region footprint
  - 18.7.5.3 Offering footprint
  - 18.7.5.4 Deployment model footprint
  - 18.7.5.5 Technology footprint
18.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
- 18.8.1 PROGRESSIVE COMPANIES
- 18.8.2 RESPONSIVE COMPANIES
- 18.8.3 DYNAMIC COMPANIES
- 18.8.4 STARTING BLOCKS
- 18.8.5 COMPETITIVE BENCHMARKING STARTUPS/SMES, 2025
18.9 COMPETITIVE SCENARIO
- 18.9.1 DEALS
- 18.9.2 OTHER DEVELOPMENTS

19 COMPANY PROFILES

19.1 KEY PLAYERS
- 19.1.1 BAYER AG
  - 19.1.1.1 Products/solutions/services offered
  - 19.1.1.2 Recent developments
    - 19.1.1.2.1 Product launches & upgrades
    - 19.1.1.2.2 Deals
    - 19.1.1.2.3 Other developments
  - 19.1.1.3 MnM view
    - 19.1.1.3.1 Key strengths
    - 19.1.1.3.2 Strategic choices
    - 19.1.1.3.3 Weaknesses and competitive threats
- 19.1.2 SIEMENS HEALTHINEERS AG
  - 19.1.2.1 Business overview
  - 19.1.2.2 Products/solutions/services offered
  - 19.1.2.3 Recent developments
    - 19.1.2.3.1 Product launches & upgrades
    - 19.1.2.3.2 Deals
    - 19.1.2.3.3 Expansions
  - 19.1.2.4 MnM view
    - 19.1.2.4.1 Key strengths
    - 19.1.2.4.2 Strategic choices
    - 19.1.2.4.3 Weaknesses and competitive threats
- 19.1.3 KONINKLIJKE PHILIPS N.V.
  - 19.1.3.1 Business overview
  - 19.1.3.2 Products/solutions/services offered
  - 19.1.3.3 Recent developments
    - 19.1.3.3.1 Product launches & upgrades
    - 19.1.3.3.2 Deals
  - 19.1.3.4 MnM view
    - 19.1.3.4.1 Key strengths
    - 19.1.3.4.2 Strategic choices
    - 19.1.3.4.3 Weaknesses and competitive threats
- 19.1.4 GE HEALTHCARE
  - 19.1.4.1 Business overview
  - 19.1.4.2 Products/solutions/services offered
  - 19.1.4.3 Recent developments
    - 19.1.4.3.1 Product launches & upgrades
    - 19.1.4.3.2 Deals
    - 19.1.4.3.3 Other developments
  - 19.1.4.4 MnM view
    - 19.1.4.4.1 Key strengths
    - 19.1.4.4.2 Strategic choices
    - 19.1.4.4.3 Weaknesses and competitive threats
- 19.1.5 FUJIFILM HOLDINGS CORPORATION
  - 19.1.5.1 Business overview
  - 19.1.5.2 Products/solutions/services offered
  - 19.1.5.3 Recent developments
    - 19.1.5.3.1 Product launches & upgrades
    - 19.1.5.3.2 Deals
    - 19.1.5.3.3 Other developments
  - 19.1.5.4 MnM view
    - 19.1.5.4.1 Key strengths
    - 19.1.5.4.2 Strategic choices
    - 19.1.5.4.3 Weaknesses and competitive threats
- 19.1.6 SECTRA AB
  - 19.1.6.1 Business overview
  - 19.1.6.2 Products/solutions/services offered
  - 19.1.6.3 Recent developments
    - 19.1.6.3.1 Product launches & upgrades
    - 19.1.6.3.2 Deals
    - 19.1.6.3.3 Other developments
- 19.1.7 CANON INC.
  - 19.1.7.1 Business overview
  - 19.1.7.2 Products/solutions/services offered
  - 19.1.7.3 Recent developments
    - 19.1.7.3.1 Product launches & upgrades
    - 19.1.7.3.2 Deals
    - 19.1.7.3.3 Other developments
- 19.1.8 AGFA-GEVAERT N.V.
  - 19.1.8.1 Business overview
  - 19.1.8.2 Products/solutions/services offered
  - 19.1.8.3 Recent developments
    - 19.1.8.3.1 Product launches & upgrades
    - 19.1.8.3.2 Deals
- 19.1.9 PACSHEALTH, LLC
  - 19.1.9.1 Business overview
  - 19.1.9.2 Products/solutions/services offered
  - 19.1.9.3 Recent developments
    - 19.1.9.3.1 Deals
- 19.1.10 QAELUM
  - 19.1.10.1 Business overview
  - 19.1.10.2 Products/solutions/services offered
  - 19.1.10.3 Recent developments
    - 19.1.10.3.1 Deals
- 19.1.11 MEDSQUARE
  - 19.1.11.1 Business overview
  - 19.1.11.2 Products/solutions/services offered
  - 19.1.11.3 Recent developments
    - 19.1.11.3.1 Product launches & upgrades
    - 19.1.11.3.2 Deals
- 19.1.12 NOVARAD
  - 19.1.12.1 Business overview
  - 19.1.12.2 Products/solutions/services offered
- 19.1.13 INFINITT HEALTHCARE CO., LTD.
  - 19.1.13.1 Business overview
  - 19.1.13.2 Products/solutions/services offered
- 19.1.14 CARESTREAM HEALTH
  - 19.1.14.1 Business overview
  - 19.1.14.2 Products/solutions/services offered
  - 19.1.14.3 Recent developments
    - 19.1.14.3.1 Product Launches & upgrades
    - 19.1.14.3.2 Deals
- 19.1.15 SHIMADZU CORPORATION
  - 19.1.15.1 Business overview
  - 19.1.15.2 Products/solutions/services offered
  - 19.1.15.3 Recent developments
    - 19.1.15.3.1 Products launches & upgrades
    - 19.1.15.3.2 Deals
- 19.1.16 NANJING PERLOVE MEDICAL EQUIPMENT CO., LTD.
  - 19.1.16.1 Business overview
  - 19.1.16.2 Products/solutions/services offered
  - 19.1.16.3 Recent developments
    - 19.1.16.3.1 Product Launches & upgrades
    - 19.1.16.3.2 Deals
- 19.1.17 NEUSOFT MEDICAL SYSTEMS CO., LTD.
  - 19.1.17.1 Business overview
  - 19.1.17.2 Products/solutions/services offered
  - 19.1.17.3 Recent developments
    - 19.1.17.3.1 Product launches & upgrades
    - 19.1.17.3.2 Deals
- 19.1.18 KONICA MINOLTA, INC
  - 19.1.18.1 Business overview
  - 19.1.18.2 Products/solutions/services offered
  - 19.1.18.3 Recent developments
    - 19.1.18.3.1 Product Launches & upgrades
    - 19.1.18.3.2 Deals
- 19.1.19 IBA
  - 19.1.19.1 Business overview
  - 19.1.19.2 Products/solutions/services offered
  - 19.1.19.3 Recent developments
    - 19.1.19.3.1 Product launches & upgrades
    - 19.1.19.3.2 Deals
- 19.1.20 LUNIT INC.
  - 19.1.20.1 Business overview
  - 19.1.20.2 Products/solutions/services offered
  - 19.1.20.3 Recent developments
    - 19.1.20.3.1 Deals
19.2 OTHER PLAYERS
- 19.2.1 QIT SYSTEME GMBH
- 19.2.2 IMALOGIX
- 19.2.3 IDOSE
- 19.2.4 MYXRAYDOSE LTD.
- 19.2.5 VIRTUAL PHANTOMS INC.

20 RESEARCH METHODOLOGY

20.1 RESEARCH APPROACH
- 20.1.1 SECONDARY RESEARCH
  - 20.1.1.1 Key data from secondary sources
- 20.1.2 PRIMARY RESEARCH
  - 20.1.2.1 Key data from primary sources
  - 20.1.2.2 Insights from primary experts
20.2 RESEARCH METHODOLOGY
20.3 MARKET SIZE ESTIMATION
20.4 MARKET BREAKDOWN DATA TRIANGULATION
20.5 MARKET SHARE ESTIMATION
20.6 STUDY ASSUMPTIONS
20.7 LIMITATIONS
- 20.7.1 SCOPE-RELATED LIMITATIONS
- 20.7.2 METHODOLOGY-RELATED LIMITATIONS
20.8 RISK ASSESSMENT

21 APPENDIX

21.1 DISCUSSION GUIDE
21.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
21.3 CUSTOMIZATION OPTIONS
21.4 RELATED REPORTS
21.5 AUTHOR DETAILS

簡介目錄圖表

List of Tables

TABLE 1 EXCHANGE RATES FOR CONVERSION TO USD
TABLE 2 RADIATION DOSE MANAGEMENT MARKET: PORTER'S FIVE FORCES ANALYSIS
TABLE 3 RADIATION DOSE MANAGEMENT MARKET: ROLE IN ECOSYSTEM
TABLE 4 INDICATIVE PRICE FOR RADIATION DOSE MANAGEMENT MARKET, BY OFFERING (2025)
TABLE 5 INDICATIVE PRICE FOR RADIATION DOSE MANAGEMENT MARKET, BY REGION (2025)
TABLE 6 RADIATION DOSE MANAGEMENT: KEY CONFERENCES AND EVENTS (2026-2027)
TABLE 7 CASE 1: REDUCING RADIATION DOSE THROUGH DOSE MONITORING AND ALERTS
TABLE 8 CASE 2: ESTABLISHING MULTI-MODALITY DOSE MANAGEMENT THROUGH RADIMETRICS
TABLE 9 CASE 3: REDUCING RADIATION DOSE THROUGH DOSE MANAGEMENT AND PROTOCOL OPTIMIZATION
TABLE 10 CASE 4: ASKLEPIOS CLINICS - ENTERPRISE-WIDE RADIATION DOSE MANAGEMENT
TABLE 11 US ADJUSTED RECIPROCAL TARIFF RATES
TABLE 12 TOP APPLICANT COUNTRIES FOR RADIATION DOSE MANAGEMENT MARKET
TABLE 13 RADIATION DOSE MANAGEMENT MARKET: KEY PATENTS
TABLE 14 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 15 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 16 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 17 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 18 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 19 REGULATORY SCENARIO IN NORTH AMERICA
TABLE 20 REGULATORY SCENARIO IN EUROPE
TABLE 21 REGULATORY SCENARIO IN ASIA PACIFIC
TABLE 22 REGULATORY SCENARIO IN LATIN AMERICA
TABLE 23 REGULATORY SCENARIO IN MIDDLE EAST & AFRICA
TABLE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS (%)
TABLE 25 BUYING CRITERIA FOR TOP THREE END USERS
TABLE 26 UNMET NEEDS IN RADIATION DOSE MANAGEMENT MARKET
TABLE 27 END USER EXPECTATIONS IN RADIATION DOSE MANAGEMENT MARKET
TABLE 28 RADIATION DOSE MANAGEMENT MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 29 SOLUTIONS OFFERED BY KEY MARKET PLAYERS
TABLE 30 RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 31 RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY REGION, 2024-2031 (USD MILLION)
TABLE 32 KEY STANDALONE SOLUTIONS OFFERED BY MARKET PLAYERS
TABLE 33 RADIATION DOSE MANAGEMENT MARKET FOR STANDALONE SOLUTIONS, BY REGION, 2024-2031 (USD MILLION)
TABLE 34 KEY INTEGRATED SOLUTIONS OFFERED BY MARKET PLAYERS
TABLE 35 RADIATION DOSE MANAGEMENT MARKET FOR INTEGRATED SOLUTIONS, BY REGION, 2024-2031 (USD MILLION)
TABLE 36 SERVICES OFFERED BY KEY MARKET PLAYERS
TABLE 37 RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 38 RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY REGION, 2024-2031 (USD MILLION)
TABLE 39 RADIATION DOSE MANAGEMENT MARKET FOR SUPPORT & MAINTENANCE SERVICES, BY REGION, 2024-2031 (USD MILLION)
TABLE 40 RADIATION DOSE MANAGEMENT MARKET FOR IMPLEMENTATION & INTEGRATION SERVICES, BY REGION, 2024-2031 (USD MILLION)
TABLE 41 RADIATION DOSE MANAGEMENT MARKET FOR CONSULTING SERVICES, BY REGION, 2024-2031 (USD MILLION)
TABLE 42 RADIATION DOSE MANAGEMENT MARKET FOR EDUCATION & TRAINING SERVICES, BY REGION, 2024-2031 (USD MILLION)
TABLE 43 RADIATION DOSE MANAGEMENT MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
TABLE 44 RADIATION DOSE MANAGEMENT MARKET FOR DOSE TRACKING & MONITORING, BY REGION, 2024-2031 (USD MILLION)
TABLE 45 RADIATION DOSE MANAGEMENT MARKET FOR DOSE ANALYTICS & BENCHMARKING, BY REGION, 2024-2031 (USD MILLION)
TABLE 46 RADIATION DOSE MANAGEMENT MARKET FOR DOSE REPORTING & REGULATORY COMPLIANCE, BY REGION, 2024-2031 (USD MILLION)
TABLE 47 RADIATION DOSE MANAGEMENT MARKET FOR PROTOCOL & DOSE OPTIMIZATION, BY REGION, 2024-2031 (USD MILLION)
TABLE 48 RADIATION DOSE MANAGEMENT MARKET FOR PATIENT RADIATION EXPOSURE MANAGEMENT, BY REGION, 2024-2031 (USD MILLION)
TABLE 49 RADIATION DOSE MANAGEMENT MARKET FOR OTHER FUNCTIONS, BY REGION, 2024-2031 (USD MILLION)
TABLE 50 RADIATION DOSE MANAGEMENT MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 51 RADIATION DOSE MANAGEMENT MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 52 RADIATION DOSE MANAGEMENT MARKET FOR AI-ENABLED TECHNOLOGY, BY REGION, 2024-2031 (USD MILLION)
TABLE 53 RADIATION DOSE MANAGEMENT MARKET FOR MACHINE LEARNING, BY REGION, 2024-2031 (USD MILLION)
TABLE 54 RADIATION DOSE MANAGEMENT MARKET FOR DEEP LEARNING, BY REGION, 2024-2031 (USD MILLION)
TABLE 55 RADIATION DOSE MANAGEMENT MARKET FOR COMPUTER VISION, BY REGION, 2024-2031 (USD MILLION)
TABLE 56 RADIATION DOSE MANAGEMENT MARKET FOR NATURAL LANGUAGE PROCESSING (NLP), BY REGION, 2024-2031 (USD MILLION)
TABLE 57 RADIATION DOSE MANAGEMENT MARKET FOR NON-AI/CONVENTIONAL TECHNOLOGY, BY REGION, 2024-2031 (USD MILLION)
TABLE 58 RADIATION DOSE MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
TABLE 59 RADIATION DOSE MANAGEMENT MARKET FOR ON-PREMISE DEPLOYMENT, BY REGION, 2024-2031 (USD MILLION)
TABLE 60 RADIATION DOSE MANAGEMENT MARKET FOR CLOUD-BASED/WEB-BASED DEPLOYMENT, BY REGION, 2024-2031 (USD MILLION)
TABLE 61 RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2024-2031 (USD MILLION)
TABLE 62 RADIATION DOSE MANAGEMENT MARKET FOR CAPITAL/ANNUAL PURCHASE MODEL, BY REGION, 2024-2031 (USD MILLION)
TABLE 63 RADIATION DOSE MANAGEMENT MARKET FOR PAY-PER-PROCEDURE MODEL, BY REGION, 2024-2031 (USD MILLION)
TABLE 64 RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2024-2031 (USD MILLION)
TABLE 65 RADIATION DOSE MANAGEMENT MARKET FOR COMPUTED TOMOGRAPHY (CT), BY REGION, 2024-2031 (USD MILLION)
TABLE 66 RADIATION DOSE MANAGEMENT MARKET FOR FLUOROSCOPY & INTERVENTIONAL IMAGING, BY REGION, 2024-2031 (USD MILLION)
TABLE 67 RADIATION DOSE MANAGEMENT MARKET FOR RADIOGRAPHY, BY REGION, 2024-2031 (USD MILLION)
TABLE 68 RADIATION DOSE MANAGEMENT MARKET FOR MAMMOGRAPHY, BY REGION, 2024-2031 (USD MILLION)
TABLE 69 RADIATION DOSE MANAGEMENT MARKET FOR NUCLEAR MEDICINE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 70 RADIATION DOSE MANAGEMENT MARKET FOR NUCLEAR MEDICINE, BY REGION, 2024-2031 (USD MILLION)
TABLE 71 RADIATION DOSE MANAGEMENT MARKET FOR PET, BY REGION, 2024-2031 (USD MILLION)
TABLE 72 RADIATION DOSE MANAGEMENT MARKET FOR SPECT, BY REGION, 2024-2031 (USD MILLION)
TABLE 73 RADIATION DOSE MANAGEMENT MARKET FOR HYBRID, BY REGION, 2024-2031 (USD MILLION)
TABLE 74 RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 75 RADIATION DOSE MANAGEMENT MARKET FOR ONCOLOGY, BY REGION, 2024-2031 (USD MILLION)
TABLE 76 RADIATION DOSE MANAGEMENT MARKET FOR CARDIOLOGY, BY REGION, 2024-2031 (USD MILLION)
TABLE 77 RADIATION DOSE MANAGEMENT MARKET FOR ORTHOPEDICS, BY REGION, 2024-2031 (USD MILLION)
TABLE 78 RADIATION DOSE MANAGEMENT MARKET FOR DENTAL, BY REGION, 2024-2031 (USD MILLION)
TABLE 79 RADIATION DOSE MANAGEMENT MARKET FOR OTHER APPLICATIONS, BY REGION, 2024-2031 (USD MILLION)
TABLE 80 RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 81 RADIATION DOSE MANAGEMENT MARKET FOR HOSPITALS & HEALTHCARE SYSTEMS, BY REGION, 2024-2031 (USD MILLION)
TABLE 82 RADIATION DOSE MANAGEMENT MARKET FOR DIAGNOSTIC & IMAGING CENTERS, BY REGION, 2024-2031 (USD MILLION)
TABLE 83 RADIATION DOSE MANAGEMENT MARKET FOR AMBULATORY CARE SETTINGS, BY REGION, 2024-2031 (USD MILLION)
TABLE 84 RADIATION DOSE MANAGEMENT MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2031 (USD MILLION)
TABLE 85 RADIATION DOSE MANAGEMENT MARKET FOR OTHER END USERS, BY REGION, 2024-2031 (USD MILLION)
TABLE 86 RADIATION DOSE MANAGEMENT MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 87 NORTH AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 88 NORTH AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 89 NORTH AMERICA: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 90 NORTH AMERICA: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 91 NORTH AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
TABLE 92 NORTH AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 93 NORTH AMERICA: RADIATION DOSE MANAGEMENT MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 94 NORTH AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
TABLE 95 NORTH AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2024-2031 (USD MILLION)
TABLE 96 NORTH AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2024-2031 (USD MILLION)
TABLE 97 NORTH AMERICA: RADIATION DOSE MANAGEMENT MARKET FOR NUCLEAR MEDICINE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 98 NORTH AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 99 NORTH AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 100 US: RADIATION DOSE MANAGEMENT MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 101 US: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 102 US: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 103 US: RADIATION DOSE MANAGEMENT MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
TABLE 104 US: RADIATION DOSE MANAGEMENT MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 105 US: RADIATION DOSE MANAGEMENT MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 106 US: RADIATION DOSE MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
TABLE 107 US: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2024-2031 (USD MILLION)
TABLE 108 US: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2024-2031 (USD MILLION)
TABLE 109 US: RADIATION DOSE MANAGEMENT MARKET FOR NUCLEAR MEDICINE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 110 US: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 111 US: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 112 CANADA: RADIATION DOSE MANAGEMENT MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 113 CANADA: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 114 CANADA: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 115 CANADA: RADIATION DOSE MANAGEMENT MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
TABLE 116 CANADA: RADIATION DOSE MANAGEMENT MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 117 CANADA: RADIATION DOSE MANAGEMENT MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 118 CANADA: RADIATION DOSE MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
TABLE 119 CANADA: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2024-2031 (USD MILLION)
TABLE 120 CANADA: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2024-2031 (USD MILLION)
TABLE 121 CANADA: RADIATION DOSE MANAGEMENT MARKET FOR NUCLEAR MEDICINE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 122 CANADA: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 123 CANADA: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 124 EUROPE: RADIATION DOSE MANAGEMENT MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 125 EUROPE: RADIATION DOSE MANAGEMENT MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 126 EUROPE: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 127 EUROPE: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 128 EUROPE: RADIATION DOSE MANAGEMENT MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
TABLE 129 EUROPE: RADIATION DOSE MANAGEMENT MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 130 EUROPE: RADIATION DOSE MANAGEMENT MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 131 EUROPE: RADIATION DOSE MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
TABLE 132 EUROPE: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2024-2031 (USD MILLION)
TABLE 133 EUROPE: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2024-2031 (USD MILLION)
TABLE 134 EUROPE: RADIATION DOSE MANAGEMENT MARKET FOR NUCLEAR MEDICINE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 135 EUROPE: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 136 EUROPE: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 137 GERMANY: RADIATION DOSE MANAGEMENT MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 138 GERMANY: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 139 GERMANY: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 140 GERMANY: RADIATION DOSE MANAGEMENT MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
TABLE 141 GERMANY: RADIATION DOSE MANAGEMENT MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 142 GERMANY: RADIATION DOSE MANAGEMENT MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 143 GERMANY: RADIATION DOSE MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
TABLE 144 GERMANY: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2024-2031 (USD MILLION)
TABLE 145 GERMANY: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2024-2031 (USD MILLION)
TABLE 146 GERMANY: RADIATION DOSE MANAGEMENT MARKET FOR NUCLEAR MEDICINE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 147 GERMANY: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 148 GERMANY: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 149 FRANCE: RADIATION DOSE MANAGEMENT MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 150 FRANCE: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 151 FRANCE: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 152 FRANCE: RADIATION DOSE MANAGEMENT MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
TABLE 153 FRANCE: RADIATION DOSE MANAGEMENT MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 154 FRANCE: RADIATION DOSE MANAGEMENT MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 155 FRANCE: RADIATION DOSE MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
TABLE 156 FRANCE: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2024-2031 (USD MILLION)
TABLE 157 FRANCE: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2024-2031 (USD MILLION)
TABLE 158 FRANCE: RADIATION DOSE MANAGEMENT MARKET FOR NUCLEAR MEDICINE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 159 FRANCE: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 160 FRANCE: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 161 UK: RADIATION DOSE MANAGEMENT MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 162 UK: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 163 UK: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 164 UK: RADIATION DOSE MANAGEMENT MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
TABLE 165 UK: RADIATION DOSE MANAGEMENT MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 166 UK: RADIATION DOSE MANAGEMENT MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 167 UK: RADIATION DOSE MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
TABLE 168 UK: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2024-2031 (USD MILLION)
TABLE 169 UK: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2024-2031 (USD MILLION)
TABLE 170 UK: RADIATION DOSE MANAGEMENT MARKET FOR NUCLEAR MEDICINE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 171 UK: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 172 UK: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 173 ITALY: RADIATION DOSE MANAGEMENT MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 174 ITALY: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 175 ITALY: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 176 ITALY: RADIATION DOSE MANAGEMENT MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
TABLE 177 ITALY: RADIATION DOSE MANAGEMENT MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 178 ITALY: RADIATION DOSE MANAGEMENT MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 179 ITALY: RADIATION DOSE MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
TABLE 180 ITALY: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2024-2031 (USD MILLION)
TABLE 181 ITALY: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2024-2031 (USD MILLION)
TABLE 182 ITALY: RADIATION DOSE MANAGEMENT MARKET FOR NUCLEAR MEDICINE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 183 ITALY: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 184 ITALY: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 185 SPAIN: RADIATION DOSE MANAGEMENT MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 186 SPAIN: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 187 SPAIN: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 188 SPAIN: RADIATION DOSE MANAGEMENT MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
TABLE 189 SPAIN: RADIATION DOSE MANAGEMENT MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 190 SPAIN: RADIATION DOSE MANAGEMENT MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 191 SPAIN: RADIATION DOSE MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
TABLE 192 SPAIN: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2024-2031 (USD MILLION)
TABLE 193 SPAIN: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2024-2031 (USD MILLION)
TABLE 194 SPAIN: RADIATION DOSE MANAGEMENT MARKET FOR NUCLEAR MEDICINE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 195 SPAIN: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 196 SPAIN: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 197 REST OF EUROPE: RADIATION DOSE MANAGEMENT MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 198 REST OF EUROPE: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 199 REST OF EUROPE: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 200 REST OF EUROPE: RADIATION DOSE MANAGEMENT MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
TABLE 201 REST OF EUROPE: RADIATION DOSE MANAGEMENT MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 202 REST OF EUROPE: RADIATION DOSE MANAGEMENT MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 203 REST OF EUROPE: RADIATION DOSE MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
TABLE 204 REST OF EUROPE: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2024-2031 (USD MILLION)
TABLE 205 REST OF EUROPE: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2024-2031 (USD MILLION)
TABLE 206 REST OF EUROPE: RADIATION DOSE MANAGEMENT MARKET FOR NUCLEAR MEDICINE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 207 REST OF EUROPE: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 208 REST OF EUROPE: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 209 ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 210 ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 211 ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 212 ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 213 ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
TABLE 214 ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 215 ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 216 ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
TABLE 217 ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2024-2031 (USD MILLION)
TABLE 218 ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2024-2031 (USD MILLION)
TABLE 219 ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET FOR NUCLEAR MEDICINE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 220 ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 221 ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 222 CHINA: RADIATION DOSE MANAGEMENT MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 223 CHINA: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 224 CHINA: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 225 CHINA: RADIATION DOSE MANAGEMENT MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
TABLE 226 CHINA: RADIATION DOSE MANAGEMENT MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 227 CHINA: RADIATION DOSE MANAGEMENT MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 228 CHINA: RADIATION DOSE MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
TABLE 229 CHINA: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2024-2031 (USD MILLION)
TABLE 230 CHINA: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2024-2031 (USD MILLION)
TABLE 231 CHINA: RADIATION DOSE MANAGEMENT MARKET FOR NUCLEAR MEDICINE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 232 CHINA: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 233 CHINA: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 234 JAPAN: RADIATION DOSE MANAGEMENT MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 235 JAPAN: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 236 JAPAN: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 237 JAPAN: RADIATION DOSE MANAGEMENT MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
TABLE 238 JAPAN: RADIATION DOSE MANAGEMENT MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 239 JAPAN: RADIATION DOSE MANAGEMENT MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 240 JAPAN: RADIATION DOSE MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
TABLE 241 JAPAN: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2024-2031 (USD MILLION)
TABLE 242 JAPAN: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2024-2031 (USD MILLION)
TABLE 243 JAPAN: RADIATION DOSE MANAGEMENT MARKET FOR NUCLEAR MEDICINE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 244 JAPAN: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 245 JAPAN: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 246 INDIA: RADIATION DOSE MANAGEMENT MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 247 INDIA: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 248 INDIA: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 249 INDIA: RADIATION DOSE MANAGEMENT MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
TABLE 250 INDIA: RADIATION DOSE MANAGEMENT MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 251 INDIA: RADIATION DOSE MANAGEMENT MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 252 INDIA: RADIATION DOSE MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
TABLE 253 INDIA: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2024-2031 (USD MILLION)
TABLE 254 INDIA: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2024-2031 (USD MILLION)
TABLE 255 INDIA: RADIATION DOSE MANAGEMENT MARKET FOR NUCLEAR MEDICINE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 256 INDIA: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 257 INDIA: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 258 AUSTRALIA: RADIATION DOSE MANAGEMENT MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 259 AUSTRALIA: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 260 AUSTRALIA: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 261 AUSTRALIA: RADIATION DOSE MANAGEMENT MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
TABLE 262 AUSTRALIA: RADIATION DOSE MANAGEMENT MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 263 AUSTRALIA: RADIATION DOSE MANAGEMENT MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 264 AUSTRALIA: RADIATION DOSE MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
TABLE 265 AUSTRALIA: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2024-2031 (USD MILLION)
TABLE 266 AUSTRALIA: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2024-2031 (USD MILLION)
TABLE 267 AUSTRALIA: RADIATION DOSE MANAGEMENT MARKET FOR NUCLEAR MEDICINE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 268 AUSTRALIA: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 269 AUSTRALIA: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 270 SOUTH KOREA: RADIATION DOSE MANAGEMENT MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 271 SOUTH KOREA: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 272 SOUTH KOREA: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 273 SOUTH KOREA: RADIATION DOSE MANAGEMENT MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
TABLE 274 SOUTH KOREA: RADIATION DOSE MANAGEMENT MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 275 SOUTH KOREA: RADIATION DOSE MANAGEMENT MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 276 SOUTH KOREA: RADIATION DOSE MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
TABLE 277 SOUTH KOREA: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2024-2031 (USD MILLION)
TABLE 278 SOUTH KOREA: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2024-2031 (USD MILLION)
TABLE 279 SOUTH KOREA: RADIATION DOSE MANAGEMENT MARKET FOR NUCLEAR MEDICINE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 280 SOUTH KOREA: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 281 SOUTH KOREA: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 282 REST OF ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 283 REST OF ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 284 REST OF ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 285 REST OF ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
TABLE 286 REST OF ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 287 REST OF ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 288 REST OF ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
TABLE 289 REST OF ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2024-2031 (USD MILLION)
TABLE 290 REST OF ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2024-2031 (USD MILLION)
TABLE 291 REST OF ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET FOR NUCLEAR MEDICINE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 292 REST OF ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 293 REST OF ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 294 LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 295 LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 296 LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 297 LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 298 LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
TABLE 299 LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 300 LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 301 LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
TABLE 302 LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2024-2031 (USD MILLION)
TABLE 303 LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2024-2031 (USD MILLION)
TABLE 304 LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET FOR NUCLEAR MEDICINE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 305 LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 306 LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 307 BRAZIL: RADIATION DOSE MANAGEMENT MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 308 BRAZIL: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 309 BRAZIL: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 310 BRAZIL: RADIATION DOSE MANAGEMENT MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
TABLE 311 BRAZIL: RADIATION DOSE MANAGEMENT MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 312 BRAZIL: RADIATION DOSE MANAGEMENT MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 313 BRAZIL: RADIATION DOSE MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
TABLE 314 BRAZIL: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2024-2031 (USD MILLION)
TABLE 315 BRAZIL: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2024-2031 (USD MILLION)
TABLE 316 BRAZIL: RADIATION DOSE MANAGEMENT MARKET FOR NUCLEAR MEDICINE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 317 BRAZIL: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 318 BRAZIL: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 319 MEXICO: RADIATION DOSE MANAGEMENT MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 320 MEXICO: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 321 MEXICO: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 322 MEXICO: RADIATION DOSE MANAGEMENT MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
TABLE 323 MEXICO: RADIATION DOSE MANAGEMENT MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 324 MEXICO: RADIATION DOSE MANAGEMENT MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 325 MEXICO: RADIATION DOSE MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
TABLE 326 MEXICO: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2024-2031 (USD MILLION)
TABLE 327 MEXICO: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2024-2031 (USD MILLION)
TABLE 328 MEXICO: RADIATION DOSE MANAGEMENT MARKET FOR NUCLEAR MEDICINE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 329 MEXICO: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 330 MEXICO: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 331 REST OF LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 332 REST OF LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 333 REST OF LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 334 REST OF LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
TABLE 335 REST OF LATAM: RADIATION DOSE MANAGEMENT MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 336 REST OF LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 337 REST OF LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
TABLE 338 REST OF LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2024-2031 (USD MILLION)
TABLE 339 REST OF LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2024-2031 (USD MILLION)
TABLE 340 REST OF LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET FOR NUCLEAR MEDICINE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 341 REST OF LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 342 REST OF LATAM: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 343 MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 344 MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 345 MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 346 MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 347 MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
TABLE 348 MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 349 MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 350 MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
TABLE 351 MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2024-2031 (USD MILLION)
TABLE 352 MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2024-2031 (USD MILLION)
TABLE 353 MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET FOR NUCLEAR MEDICINE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 354 MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 355 MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 356 GCC: RADIATION DOSE MANAGEMENT MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 357 GCC: RADIATION DOSE MANAGEMENT MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 358 GCC: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 359 GCC: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 360 GCC: RADIATION DOSE MANAGEMENT MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
TABLE 361 GCC: RADIATION DOSE MANAGEMENT MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 362 GCC: RADIATION DOSE MANAGEMENT MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 363 GCC: RADIATION DOSE MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
TABLE 364 GCC: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2024-2031 (USD MILLION)
TABLE 365 GCC: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2024-2031 (USD MILLION)
TABLE 366 GCC: RADIATION DOSE MANAGEMENT MARKET FOR NUCLEAR MEDICINE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 367 GCC: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 368 GCC: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 369 SAUDI ARABIA: RADIATION DOSE MANAGEMENT MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 370 SAUDI ARABIA: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 371 SAUDI ARABIA: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 372 SAUDI ARABIA: RADIATION DOSE MANAGEMENT MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
TABLE 373 SAUDI ARABIA: RADIATION DOSE MANAGEMENT MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 374 SAUDI ARABIA: RADIATION DOSE MANAGEMENT MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 375 SAUDI ARABIA: RADIATION DOSE MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
TABLE 376 SAUDI ARABIA: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2024-2031 (USD MILLION)
TABLE 377 SAUDI ARABIA: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2024-2031 (USD MILLION)
TABLE 378 SAUDI ARABIA: RADIATION DOSE MANAGEMENT MARKET FOR NUCLEAR MEDICINE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 379 SAUDI ARABIA: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 380 SAUDI ARABIA: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 381 UAE: RADIATION DOSE MANAGEMENT MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 382 UAE: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 383 UAE: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 384 UAE: RADIATION DOSE MANAGEMENT MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
TABLE 385 UAE: RADIATION DOSE MANAGEMENT MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 386 UAE: RADIATION DOSE MANAGEMENT MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 387 UAE: RADIATION DOSE MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
TABLE 388 UAE: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2024-2031 (USD MILLION)
TABLE 389 UAE: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2024-2031 (USD MILLION)
TABLE 390 UAE: RADIATION DOSE MANAGEMENT MARKET FOR NUCLEAR MEDICINE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 391 UAE: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 392 UAE: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 393 REST OF GCC: RADIATION DOSE MANAGEMENT MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 394 REST OF GCC: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 395 REST OF GCC: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 396 REST OF GCC: RADIATION DOSE MANAGEMENT MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
TABLE 397 REST OF GCC: RADIATION DOSE MANAGEMENT MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 398 REST OF GCC: RADIATION DOSE MANAGEMENT MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 399 REST OF GCC: RADIATION DOSE MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
TABLE 400 REST OF GCC: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2024-2031 (USD MILLION)
TABLE 401 REST OF GCC: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2024-2031 (USD MILLION)
TABLE 402 REST OF GCC: RADIATION DOSE MANAGEMENT MARKET FOR NUCLEAR MEDICINE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 403 REST OF GCC: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 404 REST OF GCC: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 405 SOUTH AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 406 SOUTH AFRICA: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 407 SOUTH AFRICA: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 408 SOUTH AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
TABLE 409 SOUTH AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 410 SOUTH AFRICA: RADIATION DOSE MANAGEMENT MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 411 SOUTH AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
TABLE 412 SOUTH AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2024-2031 (USD MILLION)
TABLE 413 SOUTH AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2024-2031 (USD MILLION)
TABLE 414 SOUTH AFRICA: RADIATION DOSE MANAGEMENT MARKET FOR NUCLEAR MEDICINE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 415 SOUTH AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 416 SOUTH AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 417 REST OF MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 418 REST OF MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 419 REST OF MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 420 REST OF MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
TABLE 421 REST OF MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 422 REST OF MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 423 REST OF MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
TABLE 424 REST OF MEA: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2024-2031 (USD MILLION)
TABLE 425 REST OF MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2024-2031 (USD MILLION)
TABLE 426 REST OF MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET FOR NUCLEAR MEDICINE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 427 REST OF MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 428 REST OF MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 429 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN RADIATION DOSE MANAGEMENT MARKET, JANUARY 2023- AUGUST 2026
TABLE 430 RADIATION DOSE MANAGEMENT MARKET: DEGREE OF COMPETITION
TABLE 431 RADIATION DOSE MANAGEMENT MARKET: REGION FOOTPRINT
TABLE 432 RADIATION DOSE MANAGEMENT MARKET: OFFERING FOOTPRINT
TABLE 433 RADIATION DOSE MANAGEMENT MARKET: DEPLOYMENT MODEL FOOTPRINT
TABLE 434 RADIATION DOSE MANAGEMENT MARKET: TECHNOLOGY FOOTPRINT
TABLE 435 RADIATION DOSE MANAGEMENT MARKET: LIST OF STARTUPS/SMES
TABLE 436 RADIATION DOSE MANAGEMENT MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES
TABLE 437 RADIATION DOSE MANAGEMENT: PRODUCT LAUNCHES AND UPGRADES (JANUARY 2023-JUNE 2026)
TABLE 438 RADIATION DOSE MANAGEMENT MARKET: DEALS (JANUARY 2023-JUNE 2026)
TABLE 439 RADIATION DOSE MANAGEMENT MARKET: OTHER DEVELOPMENTS (JANUARY 2023-JUNE 2026)
TABLE 440 BAYER AG: BUSINESS OVERVIEW
TABLE 441 BAYER AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 442 BAYER AG: PRODUCT LAUNCHES & UPGRADES, JANUARY 2023-AUGUST 2026
TABLE 443 BAYER AG: DEALS, JANUARY 2023-AUGUST 2026
TABLE 444 BAYER AG: OTHER DEVELOPMENTS, JANUARY 2023-AUGUST 2026
TABLE 445 SIEMENS HEALTHINEERS AG: BUSINESS OVERVIEW
TABLE 446 SIEMENS HEALTHINEERS AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 447 SIEMENS HEALTHINEERS AG: PRODUCT LAUNCHES & UPGRADES, JANUARY 2023- AUGUST 2026
TABLE 448 SIEMENS HEALTHINEERS AG: DEALS, JANUARY 2023- AUGUST 2026
TABLE 449 SIEMENS HEALTHINEERS AG: EXPANSIONS, JANUARY 2023-AUGUST 2026
TABLE 450 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW
TABLE 451 KONINKLIJKE PHILIPS N.V.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 452 KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES & UPGRADES, JANUARY 2023-AUGUST 2026
TABLE 453 KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2023-AUGUST 2026
TABLE 454 GE HEALTHCARE: BUSINESS OVERVIEW
TABLE 455 GE HEALTHCARE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 456 GE HEALTHCARE: PRODUCT LAUNCHES & UPGRADES, JANUARY 2023- AUGUST 2026
TABLE 457 GE HEALTHCARE: DEALS, JANUARY 2023-AUGUST 2026
TABLE 458 GE HEALTHCARE: OTHER DEVELOPMENTS, JANUARY 2023-AUGUST 2026
TABLE 459 FUJIFILM HOLDINGS CORPORATION: BUSINESS OVERVIEW
TABLE 460 FUJIFILM HOLDINGS CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 461 FUJIFILM HOLDINGS CORPORATION: PRODUCT LAUNCHES & UPGRADES, JANUARY 2023-AUGUST 2026
TABLE 462 FUJIFILM HOLDINGS CORPORATION: DEALS, JANUARY 2023-AUGUST 2026
TABLE 463 FUJIFILM HOLDINGS CORPORATION: OTHER DEVELOPMENTS, JANUARY 2023-AUGUST 2026
TABLE 464 SECTRA AB: BUSINESS OVERVIEW
TABLE 465 SECTRA AB: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 466 SECTRA AB: PRODUCT LAUNCHES & UPGRADES, JANUARY 2023- AUGUST 2026
TABLE 467 SECTRA AB: DEALS, JANUARY 2023-AUGUST 2026
TABLE 468 SECTRA AB: OTHER DEVELOPMENTS, JANUARY 2023-AUGUST 2026
TABLE 469 CANON INC.: BUSINESS OVERVIEW
TABLE 470 CANON INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 471 CANON INC.: PRODUCT LAUNCHES & UPGRADES, JANUARY 2023-AUGUST 2026
TABLE 472 CANON INC.: DEALS, JANUARY 2023-AUGUST 2026
TABLE 473 CANON INC.: OTHER DEVELOPMENTS, JANUARY 2023-AUGUST 2026
TABLE 474 AGFA-GEVAERT N.V.: BUSINESS OVERVIEW
TABLE 475 AGFA-GEVAERT N.V.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 476 AGFA-GEVAERT N.V.: PRODUCT LAUNCHES & UPGRADES, JANUARY 2023-AUGUST 2026
TABLE 477 AGFA-GEVAERT N.V.: DEALS, JANUARY 2023-AUGUST 2026
TABLE 478 PACSHEALTH, LLC: BUSINESS OVERVIEW
TABLE 479 PACSHEALTH, LLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 480 PACSHEALTH, LLC: DEALS, JANUARY 2023-AUGUST 2026
TABLE 481 QAELUM: BUSINESS OVERVIEW
TABLE 482 QAELUM: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 483 QAELUM: DEALS, JANUARY 2023-AUGUST 2026
TABLE 484 MEDSQUARE: BUSINESS OVERVIEW
TABLE 485 MEDSQUARE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 486 MEDSQUARE: PRODUCT LAUNCHES & UPGRADES, JANUARY 2023-AUGUST 2026
TABLE 487 MEDSQUARE: DEALS, JANUARY 2023-AUGUST 2026
TABLE 488 NOVARAD: BUSINESS OVERVIEW
TABLE 489 NOVARAD: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 490 INFINITT HEALTHCARE CO., LTD.: BUSINESS OVERVIEW
TABLE 491 INFINITT HEALTHCARE CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 492 CARESTREAM HEALTH: BUSINESS OVERVIEW
TABLE 493 CARESTREAM HEALTH: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 494 CARESTREAM HEALTH: PRODUCT LAUNCHES & UPGRADES, JANUARY 2023- AUGUST 2026
TABLE 495 CARESTREAM HEALTH: DEALS, JANUARY 2023-AUGUST 2026
TABLE 496 SHIMADZU CORPORATION: BUSINESS OVERVIEW
TABLE 497 SHIMADZU CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 498 SHIMADZU CORPORATION: PRODUCTS LAUNCHES & UPGRADES, JANUARY 2023-AUGUST 2026
TABLE 499 SHIMADZU CORPORATION: DEALS, JANUARY 2023-AUGUST 2026
TABLE 500 NANJING PERLOVE MEDICAL EQUIPMENT CO., LTD.: BUSINESS OVERVIEW
TABLE 501 NANJING PERLOVE MEDICAL EQUIPMENT CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 502 NANJING PERLOVE MEDICAL EQUIPMENT CO., LTD.: PRODUCT LAUNCHES & UPGRADES, JANUARY 2023-AUGUST 2026
TABLE 503 NANJING PERLOVE MEDICAL EQUIPMENT CO., LTD.: DEALS, JANUARY 2023-AUGUST 2026
TABLE 504 NEUSOFT MEDICAL SYSTEMS CO., LTD.: BUSINESS OVERVIEW
TABLE 505 NEUSOFT MEDICAL SYSTEMS CO., LTD.: PRODUCTS/SOLUTIONS/ SERVICES OFFERED
TABLE 506 NEUSOFT MEDICAL SYSTEMS CO., LTD.: PRODUCT LAUNCHES & UPGRADES, JANUARY 2023-AUGUST 2026
TABLE 507 NEUSOFT MEDICAL SYSTEMS CO., LTD.: DEALS, JANUARY 2023-AUGUST 2026
TABLE 508 KONICA MINOLTA, INC.: BUSINESS OVERVIEW
TABLE 509 KONICA MINOLTA, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 510 KONICA MINOLTA, INC.: PRODUCT LAUNCHES & UPGRADES, JANUARY 2023-AUGUST 2026
TABLE 511 KONICA MINOLTA, INC.: DEALS, JANUARY 2023-AUGUST 2026
TABLE 512 IBA: BUSINESS OVERVIEW
TABLE 513 IBA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 514 IBA: PRODUCT LAUNCHES & UPGRADES, JANUARY 2023-AUGUST 2026
TABLE 515 IBA: DEALS, JANUARY 2023-AUGUST 2026
TABLE 516 LUNIT INC.: BUSINESS OVERVIEW
TABLE 517 LUNIT INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 518 LUNIT INC.: DEALS, JANUARY 2023-AUGUST 2026
TABLE 519 RISK ASSESSMENT: RADIATION DOSE MANAGEMENT MARKET

List of Figures

FIGURE 1 RADIATION DOSE MANAGEMENT MARKET SEGMENTATION
FIGURE 2 MARKET SCENARIO
FIGURE 3 GLOBAL RADIATION DOSE MANAGEMENT MARKET, 2024-2031
FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN RADIATION DOSE MANAGEMENT MARKET, 2023-2026
FIGURE 5 DISRUPTIONS INFLUENCING GROWTH OF RADIATION DOSE MANAGEMENT MARKET
FIGURE 6 HIGH-GROWTH SEGMENTS IN RADIATION DOSE MANAGEMENT MARKET, 2026-2031
FIGURE 7 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN RADIATION DOSE MANAGEMENT MARKET DURING FORECAST PERIOD
FIGURE 8 INCREASING ADOPTION OF ADVANCED DOSE MONITORING AND OPTIMIZATION SOLUTIONS TO DRIVE MARKET GROWTH
FIGURE 9 SOLUTIONS ACCOUNTED FOR LARGEST MARKET SHARE IN NORTH AMERICA IN 2025
FIGURE 10 INDIA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
FIGURE 11 RADIATION DOSE MANAGEMENT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 12 RADIATION DOSE MANAGEMENT MARKET: PORTER'S FIVE FORCES ANALYSIS
FIGURE 13 RADIATION DOSE MANAGEMENT MARKET: VALUE CHAIN ANALYSIS
FIGURE 14 RADIATION DOSE MANAGEMENT MARKET: ECOSYSTEM ANALYSIS
FIGURE 15 REVENUE SHIFTS AND NEW REVENUE POCKETS FOR RADIATION DOSE MANAGEMENT MARKET
FIGURE 16 RECENT FUNDING OF SELECTED PLAYERS IN RDM MARKET
FIGURE 17 PATENT PUBLICATION TRENDS IN RADIATION DOSE MANAGEMENT MARKET, 2015-2026
FIGURE 18 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR RADIATION DOSE MANAGEMENT PATENTS, 2015-2026
FIGURE 19 RADIATION DOSE MANAGEMENT MARKET: TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR PATENTS (JANUARY 2015-AUGUST 2026)
FIGURE 20 POTENTIAL OF AI/GEN AI IN RADIATION DOSE MANAGEMENT MARKET
FIGURE 21 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS
FIGURE 22 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS
FIGURE 23 RADIATION DOSE MANAGEMENT: KEY BUYING CRITERIA FOR TOP THREE END USERS
FIGURE 24 NORTH AMERICA: RADIATION DOSE MANAGEMENT MARKET SNAPSHOT
FIGURE 25 ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET SNAPSHOT
FIGURE 26 REVENUE SHARE ANALYSIS OF KEY PLAYERS
FIGURE 27 MARKET SHARE ANALYSIS, BY KEY PLAYER (2025)
FIGURE 28 RADIATION DOSE MANAGEMENT MARKET: BRAND COMPARISON
FIGURE 29 EV/EBITDA OF KEY VENDORS
FIGURE 30 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF VENDORS
FIGURE 31 RADIATION DOSE MANAGEMENT MARKET: KEY PLAYERS, 2025
FIGURE 32 RADIATION DOSE MANAGEMENT MARKET: COMPANY FOOTPRINT
FIGURE 33 COMPANY EVALUATION MATRIX FOR STARTUPS/SMES (2025)
FIGURE 34 BAYER AG: COMPANY SNAPSHOT (2025)
FIGURE 35 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2025)
FIGURE 36 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2025)
FIGURE 37 GE HEALTHCARE: COMPANY SNAPSHOT (2025)
FIGURE 38 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT (2026)
FIGURE 39 SECTRA AB: COMPANY SNAPSHOT (2026)
FIGURE 40 CANON INC.: COMPANY SNAPSHOT (2025)
FIGURE 41 AGFA-GEVAERT N.V.: COMPANY SNAPSHOT (2025)
FIGURE 42 SHIMADZU CORPORATION: COMPANY SNAPSHOT (2026)
FIGURE 43 KONICA MINOLTA, INC.: COMPANY SNAPSHOT (2026)
FIGURE 44 IBA: COMPANY SNAPSHOT (2025)
FIGURE 45 LUNIT INC.: COMPANY SNAPSHOT (2025)
FIGURE 46 RESEARCH DESIGN
FIGURE 47 PRIMARY SOURCES
FIGURE 48 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 49 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
FIGURE 50 BOTTOM-UP APPROACH
FIGURE 51 TOP-DOWN APPROACH
FIGURE 52 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 53 RADIATION DOSE MANAGEMENT MARKET: CAGR PROJECTION ANALYSIS
FIGURE 54 DATA TRIANGULATION METHODOLOGY